Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Predictmedix ( (TSE:PMED) ) has shared an update.
Predictmedix AI Inc. plans to rebrand as QScreen AI Inc., with a new ticker symbol QAI, marking a strategic shift to position itself as a leading healthcare innovator at the intersection of artificial intelligence, quantum-inspired computing and data-driven health solutions, subject to regulatory approval. Leveraging more than 720,000 real-world health scans from its SmartHealth AI Stations, the company aims to use quantum-inspired algorithms to enhance preventive screening, diagnostics and personalized care with higher accuracy and inclusivity on standard hardware, while onboarding strategic industry experts to drive global commercialization and strengthen its competitive position in the emerging quantum-AI healthcare market.
The most recent analyst rating on (TSE:PMED) stock is a Hold with a C$0.06 price target. To see the full list of analyst forecasts on Predictmedix stock, see the TSE:PMED Stock Forecast page.
Spark’s Take on TSE:PMED Stock
According to Spark, TipRanks’ AI Analyst, TSE:PMED is a Neutral.
The score is held down primarily by very weak financial performance (minimal revenue, persistent losses, negative free cash flow, and negative equity). Technicals are mixed but not strongly bearish, and recent corporate announcements/financings are supportive; however, valuation is constrained by ongoing losses and the lack of a dividend yield.
To see Spark’s full report on TSE:PMED stock, click here.
More about Predictmedix
Predictmedix AI Inc. is an emerging healthcare technology company that provides rapid health screening and remote patient care solutions globally. Its SmartHealth AI stations use proprietary artificial intelligence and multispectral cameras to analyze physiological data and predict a range of health issues, from vital parameters and impairment to fatigue and mental illness, while its remote care platform equips medical professionals with AI-powered tools to improve patient outcomes.
YTD Price Performance: -21.43%
Average Trading Volume: 216,246
Technical Sentiment Signal: Buy
Current Market Cap: C$11.37M
See more data about PMED stock on TipRanks’ Stock Analysis page.